Arizona startup HealthTell has raised $26 million - showing that despite the ugly PR around Theranos, single-drop-of-blood startups can still raise capital.
The Palo Alto purveyor of single-drop-of-blood diagnostics is working to keep its core mission alive. But will Theranos be able?
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.
Alabama startup CirculoGene Theranostics has released a new liquid biopsy test for cancer monitoring - but will it stick?